Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors

This study has suspended participant recruitment.
(OHSU IRB closed study to further enrollment 2/17/2006)
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
OHSU Knight Cancer Institute
ClinicalTrials.gov Identifier:
NCT00238173
First received: October 12, 2005
Last updated: September 22, 2011
Last verified: March 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: No date given
  Primary Completion Date: February 2006 (Final data collection date for primary outcome measure)